Page 17 - InsideOut Magazine

NOW AVAILABLE
Novoeight®
(Antihemophilic Factor [Recombinant]) —
an evolution in treatment for hospital patients with hemophilia A
STORAGE
UP30MONTHS TO refrigerated storage1
USABILITY
14 mL pre-fifilled diluent SYRINGE
Facilitates quick reconstitution and consistent preparation of treatment
36˚F to 46˚F
VALUE
VIAL SIZES
FLEXIBILITY
86 F
6
UP O TO
4-HOUR
STORAGE TIME
after reconstitution1
• Longest of all recombinant
Novoeight® — a proven safe and effective tr
for hospital patients with hemophilia A1
Indicated for use in adults and children with hemophilia A for: • Control and prevention of bleeding
• Perioperative management
• Routine prophylaxis to prevent or reduce the frequency
of bleeding episodes
Talk to your authorized distributor to learn more about Novoeight® or visit NovoeightPro.com for answers and resources.
ASD Healthcare • 1-800-746-6273
References: 1. Novoeight® [package insert]. Plainsboro, NJ: Novo Nordisk Inc.; 2014. 2. ADVATETM [package insert]. Westlake Village, CA: Baxter Healthcare Corp.; 2014. 3. ELOCTATE® [package insert]. Cambridge, MA: Biogen Idec Inc.; 2014. 4. Helixate® FS [package insert]. Whippany, NJ: Bayer HealthCare LLC; 2014. 5. Kogenate® FS [package insert]. Tarrytown, NY: Bayer HealthCare LLC; 2014.
6. RECOMBINATETM [package insert]. Westlake Village, CA: Baxter Healthcare Corp.; 2014. 7. XYNTHA® [package insert]. Philadelphia, PA: Wyeth Pharmaceuticals Inc., 2014.
Please see Brief Summary of Prescribing Information on the adjacent page.
Novo Nordisk Inc., 800 Scudders Mill Road, Plainsboro, New Jersey 08536 U.S.A.
Novoeight® is a registered trademark of Novo Nordisk Health Care AG.
© 2015 Novo Nordisk All rights reserved. 0315-00026032-1 April 2015 ASD Healthcare | 15
FOR 12 MONTHS
Room temperature storage
Please see Prescribing Information for complete storage instructions.
factor VIII products1-7
Multiple dose strengths help infuse patients with fewer vials1
r
e
e
a
at
tm
me
e
n
n
t
t